RecruitingNot Applicable

Comparison the Analgesic Efficacy of Ultrasonographic Bilateral TAP and Anesthetic Infiltration Into the Surgery Field for Laparoscopic Unilateral TEP Herniorrhaphy

Turkey (Türkiye)60 participantsStarted 2025-09-04

Plain-language summary

Laparoscopic inguinal hernia repair is a common surgical procedure, but postoperative pain management remains a challenge. This prospective, randomized study aims to compare the analgesic efficacy of preperitoneal and surgical site anesthetic infiltration with ultrasound-guided bilateral transversus abdominis plane (TAP) block in patients undergoing laparoscopic unilateral total extraperitoneal (TEP) herniorrhaphy. Sixty patients will be randomly allocated into two groups: Group-I will receive preperitoneal and surgical site infiltration with bupivacaine, while Group-II will receive ultrasound-guided bilateral TAP block with bupivacaine. The primary outcomes will be postoperative pain scores assessed using the visual analog scale (VAS) and additional analgesic requirements. Secondary outcomes will include postoperative hospital stay duration and cost-effectiveness. Demographic data, ASA scores, comorbidities, and operation times will be recorded. Postoperative pain will be managed with a multimodal approach, including paracetamol and NSAIDs. Rescue analgesia will be provided with intravenous paracetamol. Statistical analysis will be performed using t-tests, ANOVA, Wilcoxon-Mann-Whitney tests, and chi-square tests, as appropriate. This study aims to determine the optimal and most beneficial method for postoperative pain management and patient comfort following laparoscopic inguinal hernia repair.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Consenting patients, * She will undergo laparoscopic hernia repair surgery, * ASA-I-II, * Between the ages of 18 and 65, * No history of anticoagulant or antiaggregant drug use, * Regional anesthesia is not contraindicated and the anesthesiologist deems -appropriate for regional anesthesia, * Under general anesthesia and will undergo laparoscopic surgery, * Fully oriented and cooperative, * Unilateral inguinal hernia, * No previous surgery for inguinal hernia, * No incision in the lower abdomen, * Not using alcohol and drugs, * No preoperative pain and * Patients without symptoms of strangulated hernia will be included in the study. Exclusion Criteria: * Patients without consent * Regional anesthesia is contraindicated, * Those who will undergo open abdominal surgery, * Not in the appropriate age range, * Chronic diseases such as uncontrolled DM and HT, * Drug allergy, * Taking anticoagulant or antiaggregant drugs, * History of chronic analgesic use, * Presence of active infection in the area to be blocked, * Will not be able to comply with postoperative pain /VAS follow-up, * Patients with ASA-III-IV, * Patients with bilateral inguinal and scrotal hernias, * Patients who have been previously operated for inguinal hernia and have an incision in the lower abdomen, * Those with a history of alcohol and drug abuse * Preoperative pain and * Those with symptoms of strangulated hernia will not be included in this study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Visual Analog Scale

Timeframe: 24 hours

Trial details

NCT IDNCT06894420

SponsorBaşakşehir Çam & Sakura City Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-06-20

Contact for this trial

Ali Bekraki, Principal Investigator

+905372437699 abekraki@hotmail.com

View on ClinicalTrials.gov More Laparoscopic Surgery trials